PDB Short entry for 2VX8 HEADER ENDOCYTOSIS,EXOCYTOSIS 01-JUL-08 2VX8 TITLE VAMP7 LONGIN DOMAIN HRB PEPTIDE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPORIN-LIKE PROTEIN RIP, VESICLE-ASSOCIATED MEMBRANE COMPND 3 PROTEIN 7; COMPND 4 CHAIN: A, B, C, D; COMPND 5 FRAGMENT: HRB, RESIDUES 136-175, VAMP7 LONGIN DOMAIN, RESIDUES 1-120; COMPND 6 SYNONYM: HRB, HIV-1 REV-BINDING PROTEIN, REV-INTERACTING PROTEIN, COMPND 7 REV/REX ACTIVATION DOMAIN-BINDING PROTEIN, VAMP7, VAMP-7, COMPND 8 SYNAPTOBREVIN-LIKE PROTEIN 1; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: CHIMERA OF HUMAN HRB AND MOUSE VAMP7 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HUMAN, MOUSE; SOURCE 4 ORGANISM_TAXID: 9606, 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX 4T-2 KEYWDS ENDOCYTOSIS, EXOCYTOSIS, MEMBRANE PROTEIN, SIGNAL-ANCHOR, SNARE, KEYWDS 2 MEMBRANE, ENDOSOME, LYSOSOME, TRANSPORT, CYTOPLASMIC VESICLE, KEYWDS 3 ENDOPLASMIC RETICULUM, PROTEIN TRANSPORT, VESICLE TRANSPORT, KEYWDS 4 TRANSMEMBRANE, GOLGI APPARATUS, CLATHRIN ADAPTOR EXPDTA X-RAY DIFFRACTION AUTHOR P.R.EVANS,D.J.OWEN,J.P.LUZIO REVDAT 3 15-MAR-17 2VX8 1 SOURCE SEQADV REVDAT 2 24-FEB-09 2VX8 1 VERSN REVDAT 1 16-SEP-08 2VX8 0 JRNL AUTH P.R.PRYOR,L.JACKSON,S.R.GRAY,M.A.EDELING,A.THOMPSON, JRNL AUTH 2 C.M.SANDERSON,P.R.EVANS,D.J.OWEN,J.P.LUZIO JRNL TITL MOLECULAR BASIS FOR THE SORTING OF THE SNARE VAMP7 INTO JRNL TITL 2 ENDOCYTIC CLATHRIN-COATED VESICLES BY THE ARFGAP HRB. JRNL REF CELL(CAMBRIDGE,MASS.) V. 134 817 2008 JRNL REFN ISSN 0092-8674 JRNL PMID 18775314 JRNL DOI 10.1016/J.CELL.2008.07.023 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0035 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 33094 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1747 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.25 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2305 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2580 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4245 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 3 REMARK 3 SOLVENT ATOMS : 170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.20000 REMARK 3 B22 (A**2) : -0.13000 REMARK 3 B33 (A**2) : 2.33000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.263 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.230 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.172 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.678 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.940 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4338 ; 0.023 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5877 ; 1.996 ; 1.952 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 533 ; 7.441 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 191 ;30.760 ;23.613 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 722 ;18.426 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;23.277 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 670 ; 0.155 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3247 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2686 ; 1.303 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4318 ; 2.319 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1652 ; 3.168 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1559 ; 5.029 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. THE CRYSTALLISED CHAIN IS A FUSION PROTEIN REMARK 3 CORRESPONDING TO RESIDUES 136-176 OF HRB LINKED BY A SINGLE REMARK 3 GLYCINE (RESIDUE 43) TO RESIDUES 1-120 OF VAMP7 THE ASYMMETRIC REMARK 3 UNIT CONTAINS 4 MOLECULES. CHAINS C AND D ARE SELF-CONTAINED. REMARK 3 CHAINS A & B SWAP THE FIRST 40 RESIDUES OR SO, CORRESPONDING TO REMARK 3 THE HRB FRAGMENT REMARK 4 REMARK 4 2VX8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-JUL-08. REMARK 100 THE PDBE ID CODE IS EBI-36735. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUN-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97930 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34876 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 78.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.29000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SIRAS REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: A SINGLE HG DERIVATIVE WAS USED REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 6000, 100MM NA CITRATE PH 4.0, REMARK 280 0.2M LICL, FLASH COOLED IN 22%PEG, 20% GLYCEROL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.75700 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 57.55100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.75700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 57.55100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15940 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 SER A 2 REMARK 465 VAL A 3 REMARK 465 ALA A 4 REMARK 465 SER A 5 REMARK 465 VAL A 6 REMARK 465 HIS A 7 REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 ILE A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 SER A 13 REMARK 465 SER A 14 REMARK 465 ALA A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 THR A 18 REMARK 465 SER A 19 REMARK 465 SER A 20 REMARK 465 LEU A 157 REMARK 465 LYS A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 SER A 161 REMARK 465 GLU A 162 REMARK 465 ASN A 163 REMARK 465 HIS A 164 REMARK 465 HIS A 165 REMARK 465 HIS A 166 REMARK 465 HIS A 167 REMARK 465 HIS A 168 REMARK 465 HIS A 169 REMARK 465 GLY B 1 REMARK 465 SER B 2 REMARK 465 VAL B 3 REMARK 465 ALA B 4 REMARK 465 SER B 5 REMARK 465 VAL B 6 REMARK 465 HIS B 7 REMARK 465 ALA B 8 REMARK 465 SER B 9 REMARK 465 ILE B 10 REMARK 465 SER B 11 REMARK 465 GLY B 12 REMARK 465 SER B 13 REMARK 465 SER B 14 REMARK 465 ALA B 15 REMARK 465 SER B 16 REMARK 465 SER B 17 REMARK 465 THR B 18 REMARK 465 SER B 19 REMARK 465 LYS B 158 REMARK 465 HIS B 159 REMARK 465 HIS B 160 REMARK 465 SER B 161 REMARK 465 GLU B 162 REMARK 465 ASN B 163 REMARK 465 HIS B 164 REMARK 465 HIS B 165 REMARK 465 HIS B 166 REMARK 465 HIS B 167 REMARK 465 HIS B 168 REMARK 465 HIS B 169 REMARK 465 GLY C 1 REMARK 465 SER C 2 REMARK 465 VAL C 3 REMARK 465 ALA C 4 REMARK 465 SER C 5 REMARK 465 VAL C 6 REMARK 465 HIS C 7 REMARK 465 ALA C 8 REMARK 465 SER C 9 REMARK 465 ILE C 10 REMARK 465 SER C 11 REMARK 465 GLY C 12 REMARK 465 SER C 13 REMARK 465 SER C 14 REMARK 465 ALA C 15 REMARK 465 SER C 16 REMARK 465 SER C 17 REMARK 465 THR C 18 REMARK 465 SER C 19 REMARK 465 SER C 20 REMARK 465 LYS C 42 REMARK 465 GLY C 43 REMARK 465 ALA C 155 REMARK 465 GLN C 156 REMARK 465 LEU C 157 REMARK 465 LYS C 158 REMARK 465 HIS C 159 REMARK 465 HIS C 160 REMARK 465 SER C 161 REMARK 465 GLU C 162 REMARK 465 ASN C 163 REMARK 465 HIS C 164 REMARK 465 HIS C 165 REMARK 465 HIS C 166 REMARK 465 HIS C 167 REMARK 465 HIS C 168 REMARK 465 HIS C 169 REMARK 465 GLY D 1 REMARK 465 SER D 2 REMARK 465 VAL D 3 REMARK 465 ALA D 4 REMARK 465 SER D 5 REMARK 465 VAL D 6 REMARK 465 HIS D 7 REMARK 465 ALA D 8 REMARK 465 SER D 9 REMARK 465 ILE D 10 REMARK 465 SER D 11 REMARK 465 GLY D 12 REMARK 465 SER D 13 REMARK 465 SER D 14 REMARK 465 ALA D 15 REMARK 465 SER D 16 REMARK 465 SER D 17 REMARK 465 THR D 18 REMARK 465 SER D 19 REMARK 465 SER D 20 REMARK 465 ASN D 41 REMARK 465 LYS D 42 REMARK 465 GLU D 114 REMARK 465 ARG D 115 REMARK 465 HIS D 159 REMARK 465 HIS D 160 REMARK 465 SER D 161 REMARK 465 GLU D 162 REMARK 465 ASN D 163 REMARK 465 HIS D 164 REMARK 465 HIS D 165 REMARK 465 HIS D 166 REMARK 465 HIS D 167 REMARK 465 HIS D 168 REMARK 465 HIS D 169 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 42 CG CD CE NZ REMARK 470 GLU A 148 CG CD OE1 OE2 REMARK 470 THR D 21 OG1 CG2 REMARK 470 LYS D 158 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN D 83 O HOH D 2027 2.13 REMARK 500 O LEU C 76 O HOH C 2011 2.16 REMARK 500 O SER B 81 O HOH B 2026 2.18 REMARK 500 O GLU C 82 O HOH C 2013 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL C 50 CB VAL C 50 CG1 -0.131 REMARK 500 CYS C 99 CB CYS C 99 SG 0.117 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL D 71 CB - CA - C ANGL. DEV. = -14.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 34 -86.91 -63.59 REMARK 500 ALA A 35 -149.38 129.77 REMARK 500 PRO A 36 -71.62 -71.98 REMARK 500 THR A 37 -82.12 81.00 REMARK 500 LEU A 40 1.41 -61.83 REMARK 500 ASN A 41 29.19 -141.21 REMARK 500 LYS A 42 53.03 16.01 REMARK 500 MET A 44 132.87 -14.41 REMARK 500 ALA A 45 45.13 -78.20 REMARK 500 ASN A 67 39.06 -91.33 REMARK 500 SER A 151 40.80 -96.34 REMARK 500 VAL A 152 -37.63 -134.62 REMARK 500 ALA A 155 57.04 -90.88 REMARK 500 ASN B 67 59.36 -95.58 REMARK 500 ARG B 102 -13.24 69.60 REMARK 500 ALA B 140 151.35 -47.72 REMARK 500 ALA C 45 -115.91 -81.83 REMARK 500 PHE C 48 128.60 171.22 REMARK 500 ALA C 59 146.33 -170.52 REMARK 500 CYS C 64 -161.64 -176.62 REMARK 500 ASN C 67 42.00 -96.82 REMARK 500 ASN C 84 163.39 174.25 REMARK 500 ARG C 102 2.82 82.32 REMARK 500 ASP C 111 -50.53 -27.50 REMARK 500 ARG C 115 -8.38 -45.69 REMARK 500 ALA C 118 -58.15 -22.74 REMARK 500 TYR C 143 -1.67 69.77 REMARK 500 GLU C 148 -95.57 -66.11 REMARK 500 PHE C 149 -19.99 -34.24 REMARK 500 ASN D 67 68.45 -101.16 REMARK 500 ARG D 102 -4.02 75.41 REMARK 500 ASP D 112 -17.07 -40.39 REMARK 500 ARG D 117 71.46 -119.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1158 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B1159 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D1159 REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUES 44-163 CORRESPOND TO THE LONGIN DOMAIN OF VAMP7 REMARK 999 RESIDUES 1-42 ARE FROM HUMAN HRB (ACCESSION NUMBER REMARK 999 NM_004504) G43 AND THE C-TERMINAL H6 (RESIDUES 163-168) REMARK 999 ARE CLONING ARTIFACTS DBREF 2VX8 A 3 42 UNP P52594 NUPL_HUMAN 136 175 DBREF 2VX8 A 44 163 UNP P70280 VAMP7_MOUSE 1 120 DBREF 2VX8 B 3 42 UNP P52594 NUPL_HUMAN 136 175 DBREF 2VX8 B 44 163 UNP P70280 VAMP7_MOUSE 1 120 DBREF 2VX8 C 3 42 UNP P52594 NUPL_HUMAN 136 175 DBREF 2VX8 C 44 163 UNP P70280 VAMP7_MOUSE 1 120 DBREF 2VX8 D 3 42 UNP P52594 NUPL_HUMAN 136 175 DBREF 2VX8 D 44 163 UNP P70280 VAMP7_MOUSE 1 120 SEQADV 2VX8 GLY A 1 UNP P70280 EXPRESSION TAG SEQADV 2VX8 SER A 2 UNP P70280 EXPRESSION TAG SEQADV 2VX8 GLY A 43 UNP P70280 LINKER SEQADV 2VX8 HIS A 164 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS A 165 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS A 166 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS A 167 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS A 168 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS A 169 UNP P70280 EXPRESSION TAG SEQADV 2VX8 GLY B 1 UNP P70280 EXPRESSION TAG SEQADV 2VX8 SER B 2 UNP P70280 EXPRESSION TAG SEQADV 2VX8 GLY B 43 UNP P70280 LINKER SEQADV 2VX8 HIS B 164 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS B 165 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS B 166 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS B 167 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS B 168 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS B 169 UNP P70280 EXPRESSION TAG SEQADV 2VX8 GLY C 1 UNP P70280 EXPRESSION TAG SEQADV 2VX8 SER C 2 UNP P70280 EXPRESSION TAG SEQADV 2VX8 GLY C 43 UNP P70280 LINKER SEQADV 2VX8 HIS C 164 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS C 165 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS C 166 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS C 167 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS C 168 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS C 169 UNP P70280 EXPRESSION TAG SEQADV 2VX8 GLY D 1 UNP P70280 EXPRESSION TAG SEQADV 2VX8 SER D 2 UNP P70280 EXPRESSION TAG SEQADV 2VX8 GLY D 43 UNP P70280 LINKER SEQADV 2VX8 HIS D 164 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS D 165 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS D 166 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS D 167 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS D 168 UNP P70280 EXPRESSION TAG SEQADV 2VX8 HIS D 169 UNP P70280 EXPRESSION TAG SEQRES 1 A 169 GLY SER VAL ALA SER VAL HIS ALA SER ILE SER GLY SER SEQRES 2 A 169 SER ALA SER SER THR SER SER THR PRO GLU VAL LYS PRO SEQRES 3 A 169 LEU LYS SER LEU LEU GLY ASP SER ALA PRO THR LEU HIS SEQRES 4 A 169 LEU ASN LYS GLY MET ALA ILE LEU PHE ALA VAL VAL ALA SEQRES 5 A 169 ARG GLY THR THR ILE LEU ALA LYS HIS ALA TRP CYS GLY SEQRES 6 A 169 GLY ASN PHE LEU GLU VAL THR GLU GLN ILE LEU ALA LYS SEQRES 7 A 169 ILE PRO SER GLU ASN ASN LYS LEU THR TYR SER HIS GLY SEQRES 8 A 169 ASN TYR LEU PHE HIS TYR ILE CYS GLN ASP ARG ILE VAL SEQRES 9 A 169 TYR LEU CYS ILE THR ASP ASP ASP PHE GLU ARG SER ARG SEQRES 10 A 169 ALA PHE SER PHE LEU ASN GLU VAL LYS LYS ARG PHE GLN SEQRES 11 A 169 THR THR TYR GLY SER ARG ALA GLN THR ALA LEU PRO TYR SEQRES 12 A 169 ALA MET ASN SER GLU PHE SER SER VAL LEU ALA ALA GLN SEQRES 13 A 169 LEU LYS HIS HIS SER GLU ASN HIS HIS HIS HIS HIS HIS SEQRES 1 B 169 GLY SER VAL ALA SER VAL HIS ALA SER ILE SER GLY SER SEQRES 2 B 169 SER ALA SER SER THR SER SER THR PRO GLU VAL LYS PRO SEQRES 3 B 169 LEU LYS SER LEU LEU GLY ASP SER ALA PRO THR LEU HIS SEQRES 4 B 169 LEU ASN LYS GLY MET ALA ILE LEU PHE ALA VAL VAL ALA SEQRES 5 B 169 ARG GLY THR THR ILE LEU ALA LYS HIS ALA TRP CYS GLY SEQRES 6 B 169 GLY ASN PHE LEU GLU VAL THR GLU GLN ILE LEU ALA LYS SEQRES 7 B 169 ILE PRO SER GLU ASN ASN LYS LEU THR TYR SER HIS GLY SEQRES 8 B 169 ASN TYR LEU PHE HIS TYR ILE CYS GLN ASP ARG ILE VAL SEQRES 9 B 169 TYR LEU CYS ILE THR ASP ASP ASP PHE GLU ARG SER ARG SEQRES 10 B 169 ALA PHE SER PHE LEU ASN GLU VAL LYS LYS ARG PHE GLN SEQRES 11 B 169 THR THR TYR GLY SER ARG ALA GLN THR ALA LEU PRO TYR SEQRES 12 B 169 ALA MET ASN SER GLU PHE SER SER VAL LEU ALA ALA GLN SEQRES 13 B 169 LEU LYS HIS HIS SER GLU ASN HIS HIS HIS HIS HIS HIS SEQRES 1 C 169 GLY SER VAL ALA SER VAL HIS ALA SER ILE SER GLY SER SEQRES 2 C 169 SER ALA SER SER THR SER SER THR PRO GLU VAL LYS PRO SEQRES 3 C 169 LEU LYS SER LEU LEU GLY ASP SER ALA PRO THR LEU HIS SEQRES 4 C 169 LEU ASN LYS GLY MET ALA ILE LEU PHE ALA VAL VAL ALA SEQRES 5 C 169 ARG GLY THR THR ILE LEU ALA LYS HIS ALA TRP CYS GLY SEQRES 6 C 169 GLY ASN PHE LEU GLU VAL THR GLU GLN ILE LEU ALA LYS SEQRES 7 C 169 ILE PRO SER GLU ASN ASN LYS LEU THR TYR SER HIS GLY SEQRES 8 C 169 ASN TYR LEU PHE HIS TYR ILE CYS GLN ASP ARG ILE VAL SEQRES 9 C 169 TYR LEU CYS ILE THR ASP ASP ASP PHE GLU ARG SER ARG SEQRES 10 C 169 ALA PHE SER PHE LEU ASN GLU VAL LYS LYS ARG PHE GLN SEQRES 11 C 169 THR THR TYR GLY SER ARG ALA GLN THR ALA LEU PRO TYR SEQRES 12 C 169 ALA MET ASN SER GLU PHE SER SER VAL LEU ALA ALA GLN SEQRES 13 C 169 LEU LYS HIS HIS SER GLU ASN HIS HIS HIS HIS HIS HIS SEQRES 1 D 169 GLY SER VAL ALA SER VAL HIS ALA SER ILE SER GLY SER SEQRES 2 D 169 SER ALA SER SER THR SER SER THR PRO GLU VAL LYS PRO SEQRES 3 D 169 LEU LYS SER LEU LEU GLY ASP SER ALA PRO THR LEU HIS SEQRES 4 D 169 LEU ASN LYS GLY MET ALA ILE LEU PHE ALA VAL VAL ALA SEQRES 5 D 169 ARG GLY THR THR ILE LEU ALA LYS HIS ALA TRP CYS GLY SEQRES 6 D 169 GLY ASN PHE LEU GLU VAL THR GLU GLN ILE LEU ALA LYS SEQRES 7 D 169 ILE PRO SER GLU ASN ASN LYS LEU THR TYR SER HIS GLY SEQRES 8 D 169 ASN TYR LEU PHE HIS TYR ILE CYS GLN ASP ARG ILE VAL SEQRES 9 D 169 TYR LEU CYS ILE THR ASP ASP ASP PHE GLU ARG SER ARG SEQRES 10 D 169 ALA PHE SER PHE LEU ASN GLU VAL LYS LYS ARG PHE GLN SEQRES 11 D 169 THR THR TYR GLY SER ARG ALA GLN THR ALA LEU PRO TYR SEQRES 12 D 169 ALA MET ASN SER GLU PHE SER SER VAL LEU ALA ALA GLN SEQRES 13 D 169 LEU LYS HIS HIS SER GLU ASN HIS HIS HIS HIS HIS HIS HET CL B1158 1 HET CL B1159 1 HET CL D1159 1 HETNAM CL CHLORIDE ION FORMUL 5 CL 3(CL 1-) FORMUL 8 HOH *170(H2 O) HELIX 1 1 LEU A 27 GLY A 32 1 6 HELIX 2 2 ASN A 67 ALA A 77 1 11 HELIX 3 3 GLU A 114 GLY A 134 1 21 HELIX 4 4 SER A 135 THR A 139 5 5 HELIX 5 5 MET A 145 ALA A 154 1 10 HELIX 6 6 LEU B 27 GLY B 32 1 6 HELIX 7 7 ASP B 33 ALA B 35 5 3 HELIX 8 8 ASN B 41 MET B 44 5 4 HELIX 9 9 ASN B 67 ILE B 79 1 13 HELIX 10 10 ARG B 117 GLY B 134 1 18 HELIX 11 11 SER B 135 THR B 139 5 5 HELIX 12 12 MET B 145 LEU B 157 1 13 HELIX 13 13 LEU C 27 GLY C 32 1 6 HELIX 14 14 ASP C 33 ALA C 35 5 3 HELIX 15 15 ASN C 67 ALA C 77 1 11 HELIX 16 16 GLU C 114 TYR C 133 1 20 HELIX 17 17 GLY C 134 THR C 139 5 6 HELIX 18 18 ASN C 146 LEU C 153 1 8 HELIX 19 19 LEU D 27 GLY D 32 1 6 HELIX 20 20 ASN D 67 ILE D 79 1 13 HELIX 21 21 ARG D 117 GLY D 134 1 18 HELIX 22 22 SER D 135 ALA D 140 1 6 HELIX 23 23 MET D 145 GLN D 156 1 12 SHEET 1 AA 6 VAL A 24 PRO A 26 0 SHEET 2 AA 6 ASN B 84 HIS B 90 1 O THR B 87 N LYS A 25 SHEET 3 AA 6 TYR B 93 GLN B 100 -1 O TYR B 93 N HIS B 90 SHEET 4 AA 6 ILE B 103 ASP B 110 -1 O ILE B 103 N GLN B 100 SHEET 5 AA 6 ILE B 46 ARG B 53 -1 N LEU B 47 O ILE B 108 SHEET 6 AA 6 THR B 56 ALA B 62 -1 O THR B 56 N ARG B 53 SHEET 1 AB 6 THR A 56 ALA A 62 0 SHEET 2 AB 6 PHE A 48 ARG A 53 -1 O ALA A 49 N HIS A 61 SHEET 3 AB 6 ILE A 103 ASP A 110 -1 O VAL A 104 N ALA A 52 SHEET 4 AB 6 TYR A 93 GLN A 100 -1 O LEU A 94 N THR A 109 SHEET 5 AB 6 ASN A 84 HIS A 90 -1 O ASN A 84 N CYS A 99 SHEET 6 AB 6 VAL B 24 PRO B 26 1 O LYS B 25 N SER A 89 SHEET 1 CA 6 VAL C 24 PRO C 26 0 SHEET 2 CA 6 ASN C 84 HIS C 90 1 O THR C 87 N LYS C 25 SHEET 3 CA 6 TYR C 93 GLN C 100 -1 O TYR C 93 N HIS C 90 SHEET 4 CA 6 ILE C 103 ASP C 110 -1 O ILE C 103 N GLN C 100 SHEET 5 CA 6 PHE C 48 ARG C 53 -1 O PHE C 48 N ILE C 108 SHEET 6 CA 6 THR C 56 ALA C 62 -1 O THR C 56 N ARG C 53 SHEET 1 DA 6 VAL D 24 PRO D 26 0 SHEET 2 DA 6 ASN D 84 HIS D 90 1 O THR D 87 N LYS D 25 SHEET 3 DA 6 TYR D 93 GLN D 100 -1 O TYR D 93 N HIS D 90 SHEET 4 DA 6 ILE D 103 ASP D 110 -1 O ILE D 103 N GLN D 100 SHEET 5 DA 6 ILE D 46 ARG D 53 -1 N LEU D 47 O ILE D 108 SHEET 6 DA 6 THR D 56 ALA D 62 -1 O THR D 56 N ARG D 53 SITE 1 AC1 4 ASP B 33 THR B 87 HIS B 96 HOH B2030 SITE 1 AC2 2 HIS A 90 LEU B 38 SITE 1 AC3 4 THR D 37 LEU D 38 HIS D 90 TYR D 93 CRYST1 105.514 115.102 55.440 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009477 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008688 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018038 0.00000